Candel Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CADL research report →
About the company
Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical firm based in Needham, Massachusetts, dedicated to developing innovative immunotherapies for cancer patients. Its pipeline features CAN-2409, which is presently in Phase II clinical trials for pancreatic and lung cancers, and has progressed to Phase III for prostate cancer.
- CEO
- Paul-Peter Tak
- IPO
- 2021
- Employees
- 38
- HQ
- Needham, MA, US
Price Chart
- Market Cap
- $539.68M
- P/E
- -10.00
- P/S
- 0.00
- P/B
- 4.44
- EV/EBITDA
- -6.89
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -60.42%
- ROIC
- -28.89%
- Revenue
- $0 · 0.00%
- Net Income
- $-38,182,000 · 30.80%
- EPS
- $-0.72 · 58.62%
- Op Income
- $-48,266,000
- FCF YoY
- -43.86%
- 52W High
- $11.36
- 52W Low
- $4.35
- 50D MA
- $8.25
- 200D MA
- $6.11
- Beta
- -0.51
- Avg Volume
- 2.09M
Get TickerSpark's AI analysis on CADL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 29, 26 | Barone Francesca | sell | 23,447 |
| Jun 29, 26 | Tyagarajan Seshu | sell | 7,000 |
| Jun 30, 26 | Manning Paul B | other | 2,199 |
| Jun 30, 26 | PAPA JOSEPH C | other | 1,331 |
| Jun 30, 26 | Loggia Nicoletta | other | 381 |
| Jun 23, 26 | Radhakrishnan Maha | other | 32,000 |
| Jun 23, 26 | Loggia Nicoletta | other | 32,000 |
| Jun 23, 26 | PAPA JOSEPH C | other | 32,000 |
| Jun 23, 26 | Benz Edward J. JR | other | 32,000 |
| Jun 23, 26 | Martell Christopher | other | 32,000 |
Our CADL coverage
Recent articles, reports, and earnings notes.
No research on CADL yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CADL report →Similar companies
Peers in the same neighborhood.